Pharmaceutical Litigation Attorney’s | Information to consider before your Diabetes Drug Lawsuit
According to statistics 29.1 million people in the United States are currently diagnosed with diabetes, and an additional 1.4 million cases are diagnosed every year. Currently there is no cure for diabetes, although it can be managed with changes in lifestyle, diet, and medications. For many it can be difficult to manage loosing weight, consuming a new diet, and manage your blood sugar levels while keeping up with daily life. So for a vast majority of those diagnosed with diabetes, daily medication will be necessary.
With the sheer amount of people being diagnosed with diabetes daily, it is no surprise the diabetes medication industry has grown to a $51.5 billion dollar industry within the United States.
As the diabetes industry continues to become more profitable more drugs are pushed to the market with a lack of long term data to show what side effects could arise after patients have been exposed to the drug for longer periods of time. At this time there are over 160 diabetes medications to choose from available to patients, however many are more commonly prescribed than others, and many of these drugs will have received FDA approval after limited clinical research.
If you or someone that you know has suffered due to side effects like Ketoacidosis, kidney failure, bone fracture, or amputation after taking diabetes medications, contact our firm for a free consultation.
Invokana is from a class of diabetes drugs known as SGLT2 inhibitors. The FDA has exposed the dangers of this class of drugs in recent safety communications. Contact us today for a free consultation regarding your diabetes drug lawsuit, 855-566-3752.
Unfortunately, for the patients who are dependent on these drugs we are also seeing an increase in the risks associated with taking some of these popular diabetes drugs. For example, according to sales, popular diabetes drug Invokana was the 6th highest sold diabetes drug in America in 2016. But we know now after a prominent medical study, referred to as CANVA, that the side effects of Invokana can included leg and foot amputations. CANVA was completed over the course of almost 9 years, which contributed to the exposure of long term side effects.
Other popular diabetes drugs, like Invokamet and Byetta, have joined Invokana atop the list of potentially unsafe prescription diabetes drugs approved by the FDA without long term data and with reports of unlabeled side effects. Some of these side effects, like the amputation risk involved with taking Invokana long term, are potentially life altering and pose a life threatening danger to the person taking them.
On March 29, 2013 Janssen Pharmaceuticals announced that their new drug Invokana had been approved by the U.S. Food and Drug Administration and would be available nationwide as a treatment for patients with type 2 diabetes. Since then, Invokana has gone on to be the number 1 prescribed SLGT2 prohibitor.
According to the Johnson & Johnson, the parent company of Janssen, who makes Invokana:
INVOKANA® continues to be the number-one prescribed SGLT2 inhibitor leading with more prescriptions than all other SGLT2 inhibitors combined in U.S. in 2017*. Since its launch, more than 14 million prescriptions have been written for INVOKANA® in the U.S.
The CANVA study of Invokana, a study originally done to determine the risks of heart attack and stroke associated with taking Invokana, concluded and was published in the New England Journal of Medicine in June of 2017. Although it may have shown a decrease in the risk of heart attack and stroke, over the course of the 8 year study at least 15 amputations were conducted, exposing an unknown and unaccounted for side effect of Invokana.
Before the FDA’s July 2017 notice that it would be requiring Invokana to carry its most serious product labeling warning, a black box label regarding risk for amputation, other side effects of Invokana were coming to light. The FDA had also previously released a memo regarding the risk of developing diabetic Ketoacidosis after taking Invokana.
Like Invokana, Actos was also a best selling drug within the United States. In 2008 Takeda Pharmaceuticals, the maker of Actos, sold $2.8 billion units of the diabetes drug.
Even though the FDA had issued a warning and required Actos to carry a labels warning about the evidence linking the drug to the increased risk of bladder cancer, the generic version of Actos was approved just a short time before Invokana in August of 2012.
Both Actos and Invokana were approved to treat patients with type 2 diabetes. During this time the FDA also initiated a study to examine the evidence and fully determine the risk of developing bladder cancer after taking Actos for a prolonged period of time.
On December 12, 2016 the FDA finally released an updated safety communication definitively tying Actos with the risk of developing bladder cancer after the conclusion of a 10 year study. Unfortunately for many who suffered after taking Actos, these results came too late. Diagnosis of bladder cancer after taking Actos became the leading issue in Actos lawsuits across the nation, ultimately forcing Takeda to pay $2.4 billion dollars to settle several thousand lawsuits.
The makers of Invokana are also currently facing lawsuits from consumers who experienced unexpected side effects. 79 cases against Invokana and Invokamet have recently been consolidated and appointed to the U.S. District Court of New Jersey. The consolidated cases include the claim of a woman who was diagnosed with diabetic Ketoacidosis following use of Invokana.
If you have developed life altering side effects after taking the diabetes drug Invokana an Invokana lawsuit may be an option for you. Greg Jones Law has helped clients force Pharmaceutical companies to take responsibility for the unsafe drugs they marketed and distributed. Many times plaintiffs in diabetes drug lawsuits would have chosen an alternative drug if they have known of all the potential side effects.
Contact our firm today online or call us at 855-566-3752 to speak with an experienced Invokana lawyer about your diabetes drug lawsuit.
What is Invokana? Information on Invokana warnings & a diabetes drug lawsuit:
Everything you need to know about Invokana side effects.
Learn more about the CANVA study that exposed amputations as a side effect of Invokana.
Our pharmaceutical attorney gives advice on an Invokana amputation lawsuit.
The details behind why people choose an Onglyza lawsuit.